Association of lung function with coronary heart disease and cardiovascular disease outcomes in elderly: The Rancho Bernardo study

Respiratory Medicine

Volumn 108, Issue 12, 2014, Pages 1779-1785

  Lee, Hwa Mu ^a,b   Liu, Michael A ^b   Barrett Connor, Elizabeth ^c   Wong, Nathan D ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiovascular disease; Coronary heart disease; Epidemiology; Pulmonary function test

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGE; AGED; ARTICLE; BODY HEIGHT; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE SEVERITY; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; ISCHEMIC HEART DISEASE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX; SMOKING; CORONARY ARTERY DISEASE; EPIDEMIOLOGY; LUNG; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SPIROMETRY; UNITED STATES; VERY ELDERLY; VITAL CAPACITY;

AGE FACTORS; AGED; AGED, 80 AND OVER; CALIFORNIA; CARDIOVASCULAR DISEASES; CORONARY ARTERY DISEASE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SPIROMETRY; VITAL CAPACITY;

EID: 84927690852     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2014.09.016     Document Type: Article

References (27)

1. Kannel WB, Hubert H, Lew EA. Vital capacity as a predictor of cardiovascular disease: the Framingham study. Am Heart J 1983; 105(2): 311-5. http://dx.doi.org/10.1016/0002-8703(83)90532-X.
2. Schroeder EB, Welch VL, Couper D, et al. Lung function and incident coronary heart disease the atherosclerosis risk in communities study. Am J Epidemiol 2003; 158(12): 1171-81. http://dx.doi.org/10.1093/aje/kwg276.
3. Sin DD, Wu L, Man SFP The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 2005; 127(6): 1952-9. http://dx.doi.org/10.1378/chest.127.6.1952.
4. Higgins MW, Keller JB. Predictors of mortality in the adult population of Tecumseh. Arch Environ Health An Int J 1970; 21(3): 418-24. http://dx.doi.org/10.1080/00039896.1970.10667260.
5. Hole DJ, Watt GCM, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996; 313(7059): 711-5. http://dx.doi.org/10.1136/bmj.313.7059.711.
6. Tockman MS, Comstock GW. Respiratory risk factors and mortality: longitudinal studies in Washington County, Maryland. Am Rev Respir Dis 1989; 140(3 Pt 2): S56-63. http://dx.doi.org/10.1164/ajrccm/140.3-Pt-2.S56.
7. Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P. Spirometric findings and mortality in never-smokers. J Clin Epidemiol 1990; 43(9): 867-73. http://dx.doi.org/10.1016/08954356(90)90070-6.
8. World Health Organization. Chronic obstructive pulmonary disease (COPD) fact sheet. World Health Organization; November 2012. website, www.who.int/mediacentre/factsheets/fs315/en/index.html [accessed 19.12.12].
9. Holguin F, Folch E, Redd SC, Mannino DM. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest 2005; 128(4): 2005-11. http://dx.doi.org/10.1378/chest.128.4.2005.
10. Pope CA, Burnett RT, Thurston GD, et al. Cardiovascular mortality and long-term exposure to particulate air pollution epidemiological evidence of general pathophysiological pathways of disease. Circulation 2004; 109(1): 71-7. http://dx.doi.org/10.1161/01.CIR.0000108927.80044.7F.
11. Stone IS, Barnes NC, Petersen SE. Chronic obstructive pulmonary disease: a modifiable risk factor for cardiovascular disease? Heart 2012; 98(14): 1055-62. http://dx.doi.org/10.1136/heartjnl-2012-301759.
12. Barrett-Connor E. The prevalence of diabetes mellitus in an adult community as determined by history or fasting hyperglycemia. Am J Epidemiol 1980; 111: 705-12.
13. Criqui MH, Barrett-Connor E, Austin M. Differences between respondents and non-respondents in a population-based cardiovascular disease study. Am J Epidemiol 1978; 108: 367-72.
14. Frette C, Barrett-Connor E, Clausen JL. Effect of active and passive smoking on ventilatory function in elderly men and women. Am J Epidemiol 1996; 143(8): 757-65.
15. Lee HM, Lee J, Lee K, Luo Y, Sin DD, Wong ND. Relation between COPD severity and global cardiovascular risk in US adults. Chest 2012; 142(5): 1118-25. http://dx.doi.org/10.1378/chest.11-2421.
16. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160(6): 1856-61. http://dx.doi.org/10.1164/ajrccm.160.6.9902115.
17. Wilson DO, Rogers RM, Wright EC, Anthonisen NR. Body weight in chronic obstructive pulmonary disease: the national institutes of health intermittent positive-pressure breathing trial. Am Rev Respir Dis 1989; 139(6): 1435-8. http://dx.doi.org/10.1164/ajrccm/139.6.1435.
18. Gray-Donald K, Gibbons L, Shapiro SH, Macklem PT, Martin JG. Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153(3): 961-6. http://dx.doi.org/10.1164/ajrccm.153.3.8630580.
19. Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157(6 Pt 1): 1791-7. http://dx.doi.org/10.1164/ajrccm.157.6.9705017.
20. Lee HM, Le H, Lee BT, Lopez VA, Wong ND. Forced vital capacity paired with Framingham risk score for prediction of all-cause mortality. Eur Respir J 2010; 36(5): 1002-6. http://dx.doi.org/10.1183/09031936.00042410.
21. Persson C, Bengtsson C, Lapidus L, Rybo E, Thiringer G, Wedel H. Peak expiratory flow and risk of cardiovascular disease and death a 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Am J Epidemiol 1986; 124(6): 942-8.
22. Cook DG, Shaper AG. Breathlessness, lung function and the risk of heart attack. Eur Heart J 1988; 9(11): 1215-22.
23. Ebi-Kryston KL. Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease, and all causes in the Whitehall study. J Clin Epidemiol 1988; 41(3): 251-60. http://dx.doi.org/10.1016/08954356(88)90129-1.
24. Knuiman MW, James AL, Divitini ML, Ryan G, Bartholomew HC, Musk AW. Lung function, respiratory symptoms, and mortality: results from the Busselton health study. Ann Epidemiol 1999; 9(5): 297-306. http://dx.doi.org/10.1016/S1047-2797(98)00066-0.
25. Kuller LH, Ockene JK, Townsend M, Browner W, Meilahn E, Wentworth DN. The epidemiology of pulmonary function and COPD mortality in the multiple risk factor intervention trial. Am Rev Respir Dis 1989; 140(3 Pt 2): S76-81. http://dx.doi.org/10.1164/ajrccm/140.3-Pt-2.S76.
26. Keys A, Aravanis C, Blackburn H, et al. Lung function as a risk factor for coronary heart disease. Am J Public Health 1972; 62(11): 1506-11. http://dx.doi.org/10.1089/dna.2011.1478.
27. Lundback B, Eriksson B, Lindberg A, Ekerljung L, Muellerova H, Larsson LG, Ronmark E. A 20-year follow-up of a population-based COPD cohort-report from the obstructive lung disease in Northern Sweden studies. J COPD 2009; 6: 263-71.